Black Rock Inc. Fusion Pharmaceuticals Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$7.9 - $21.32 $766,213 - $2.07 Million	96,989 Added 23.1%	516,795 $11 Million
Q4 2023 Feb 13, 2024	BUY	$2.48 - $9.65 $1.02 Million - $3.97 Million	411,553 Added 4986.71%	419,806 $4.03 Million
Q1 2022 May 12, 2022	SELL	$4.53 - $8.57 $5,889 - $11,141	-1,300 Reduced 13.61%	8,253 $64,000
Q4 2021 Feb 10, 2022	SELL	$4.17 - $7.78 $1.69 Million - $3.15 Million	-404,703 Reduced 97.69%	9,553 $40,000
Q3 2021 Nov 09, 2021	SELL	$7.83 - $9.41 $438,848 - $527,402	-56,047 Reduced 11.92%	414,256 $3.28 Million
Q2 2021 Aug 11, 2021	BUY	$7.97 - $10.66 $3.75 Million - $5.01 Million	470,303 New	470,303 $3.8 Million

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.